摘要:
A method for delivering optical stimulation comprises transfecting a target tissue with a light-sensitive channel protein sensitive to light in a wavelength range, delivering light in the wavelength range to the target tissue via an optical stimulation device, substantially simultaneously with delivering light to the target tissue, sensing bioelectric signals, determining a patient therapeutic state based on the bioelectric signals, and adjusting the delivery of the light to the target tissue based on the sensed patient therapeutic state.
摘要:
The present invention is directed to methods and systems for the treatment of inborn genetic errors or other defects that cause deficiencies of active enzymes or proteins within the cells of the central nervous system. Such methods and systems generally comprise an implantable catheter system designed for the chronic delivery of specially formulated proteins to intrathecal, intracerebroventricular, and/or intraparenchymal regions of the central nervous system. The invention has application in the neuropathic aspects of the broad category of lysosomal storage diseases. These genetic based diseases are the result of insufficient enzyme activity to catabolize specific substances, which thereby accumulate in the cellular lysosomes.
摘要:
A method of improving the breakdown strength of polymer multi-layer (PML) capacitors is provided. The method comprises removing metal, specifically, aluminum, from the cut edge. This is done by either etching back the metal electrode layers in either basic or acidic solution or by anodizing the metal to cover that portion of the metal at the edge with an oxide. Removing the metal from the cut edge increases the breakdown strength of the PML capacitors by a factor of two or more.
摘要:
An implantable cardioverter having circuitry for generating high energy cardioversion and defibrillation pulses. The output circuitry is so configured that it may provide simultaneous pulse, multiple electrode; sequential pulse, multiple electrode; or single pulse, two electrode defibrillation and/or cardioversion pulse regimens. The output circuitry is configured to allow delivery of energy sequentially from two capacitor banks during sequential pulse regimens and to deliver the energy stored in both capacitor banks simultaneously during simultaneous pulse, multiple electrode and single pulse, two electrode defibrillation pulse regimens.
摘要:
The present invention is directed to systems and methods for delivering therapy for a cardiac disorder, wherein the system comprises a source for supplying a protein formulation containing a protein that is otherwise deficient in cardiac cells in a patient with a cardiac disorder, and a catheter having a proximal end and a distal end for delivering the protein formulation to the pericardial sac region of a human heart.
摘要:
Techniques are described that allow an implantable device to sense gastric data and activity data from a patient, and estimate the patient's amount of energy consumed and energy expended based on the sensed data. A system provides feedback to the patient, a family member, or a doctor about the patient's energy consumed, energy expended, and net energy. The data may be provided in table or graphical format, and may show daily or weekly energy balance data or may show a trend of the daily or weekly energy data. The patient may receive feedback by an implanted alert module that provides and audio alert or a vibration alert. In addition, data acquired by the system may be used to adjust the patient's stimulation therapy parameters.
摘要:
Techniques are described that allow an implantable device to sense gastric data and activity data from a patient, and estimate the patient's amount of energy consumed and energy expended based on the sensed data. A system provides feedback to the patient, a family member, or a doctor about the patient's energy consumed, energy expended, and net energy. The data may be provided in table or graphical format, and may show daily or weekly energy balance data or may show a trend of the daily or weekly energy data. The patient may receive feedback by an implanted alert module that provides and audio alert or a vibration alert. In addition, data acquired by the system may be used to adjust the patient's stimulation therapy parameters.
摘要:
An improved implantable sensor system is disclosed that includes an array of sensors. Each of the sensors is associated with a protective member that prevents the sensor from interacting with the surrounding environment. At a selected time, the protective member may be disabled, thereby allowing the sensor to begin sensing signals within a living body. In one embodiment, the protective member is formed of a conductive material that can oxidize, is biocompatible, bio-absorbable, and that may be dissolved in solution such as blood upon application of an electric potential. In another embodiment, the protective member is formed of a dissolvable member that dissolves within the body over a predetermined time period.
摘要:
An alternative mechanism in an implantable device for meeting the physician's need for a stored electrogram and/or other stored physiologic signal associated with a detected arrhythmic or other physiological event without the undesirable current drain associated with continuous operation of a sense amplifier and a looping memory. The device regularly but intermittently activates a sense amplifier or other sensor and associated memory circuitry, independent of detection of arrhythmias. The device may temporarily store only a single record, replacing it with new records as they are stored, or may store multiple records, replacing the oldest stored record with the newest stored record. On detection of an arrhythmia or other defined physiological event, the device may simply transfer the one or more temporarily stored electrogram strips to permanent storage, for later use by the physician in diagnosing the condition of the patient prior to detection of the event.
摘要:
An implantable cardioverter/defibrillator capable of detecting fibrillation and other tachyarrhythmias and of generating high energy cardioversion and defibrillation pulses. The device delivers cardioversion pulses and defibrillation pulses synchronized to heart rhythm, wherever possible. Delivery of cardioversion pulses requires verification of the continuing presence of a tachyarrhythmia, following charge up of the output capacitor in the pulse generator. In the event that cardioversion therapy is aborted, the charge on the capacitor is retained until subsequent detection of termination of the tachyarrthythmia. Defibrillation pulses are delivered synchronized to heart rhythm, wherever possible, but are delivered asynchronously if synchronization is not possible. Following delivery of a cardioversion or defibrillation pulse, the charge remaining on the capacitor is retained until detection of tachyarrhythmia or fibrillation termination, respectively.